Yuen WY, Jonkman MF; Journal of the American Academy of Dermatology (May 2011)

Source: J Am Acad Dermatol

Tags:

BACKGROUND:  Squamous cell carcinoma (SCC) is the most severe complication and most common cause of death in patients with recessive dystrophic epidermolysis bullosa. The risk of developing SCC among patients with junctional epidermolysis bullosa (JEB) is unclear from the literature; however, in our center we noticed an unexpected number of SCCs among adult patients with JEB.

Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, the BRIM-3 Study Group; New England Journal of Medicine (NEJM) (Jun 2011)

Source: N Engl J Med

Tags:

dacarbazine

Melanoma

vemurafenib

Source: Br J Dermatol

Abuabara K, Lee H, Kimball AB; British Journal of Dermatology (Jul 2011)

Tags:

adalimumab

Angina Pectoris/MI

ciclosporin

efalizumab

infliximab

methotrexate

Psoriasis

Source: J Dermatol Treat

Sola-Ortigosa J, Sánchez-Regaña M, Umbert-Millet P; Journal of Dermatological Treatment (Jul 2011)

Tags:

adalimumab

Psoriasis